Loghavi S, Farhat A, Jamison TJ, El Hajjar G, Bataller A, Wang SA, Wang W, Tang G, Quesada AE, Bazinet A, Cuglievan B, DiNardo CD, Montalban-Bravo G, Takahashi K, Short NJ, Abbas HA , Kadia T, Ravandi F, Daver N, Jabbour E, Borthakur G, Andreeff M, Medeiros LJ, Kantarjian HM, Issa GC . Immunophenoty
— 2026cited by 0position: selected
Zhu Y, Wang SA, Chien K, Patel KP, Lenskaya V, Medeiros LJ, Abbas HA , Loghavi S . Presumed tumor-infiltrating clonal hematopoiesis unmasking a concomitant systemic mastocytosis with associated myeloid neoplasm in a patient with metastatic melanoma. Virchows Arch, 2026. e-Pub 2026. PMID: 41811504.
— 2026cited by 0position: selected
Arnuk A, Han C, Lawal AE, Wang B, Karma S, Zhang Z, Yassouf MY, Rajendran SH, Chandok H, Eller ML, Sajedi S, McKenna M, Herman E, Hagen L, Nadorp B, Mo Z, Orellana H, Tsirigos A, Miura P, Abbas HA , Aifantis I, Wang E . Epigenetic reactivation of the tumor suppressor ZBTB7A by KDM4 inhibition in hum
— 2026cited by 0position: selected
Senapati, J, Croden, J, Garcia-Manero, G, Takahashi, K, Daver, N, Kadia, TM, Borthakur, G, Short, NJ, Jabbour, EJ, Haddad, FG, Marvin-Peek, J, Abbas, HA , Bose, P, Tang, G, Loghavi, S, Shpall, E, Ramdial, JL, Popat, UR, Champlin, RE, Ravandi-Kashani, F, Kantarjian, HM, DiNardo, C . Outcomes of thera
— 2026cited by 0position: selected
Garcia MB, Wang B, Sheikh I, El Hajjar G, McCall D, Nunez C, Gibson A, Lorenzi PL, Issa GC, Cuglievan B, Abbas HA . High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition. Mol Cell Proteomics 25(3):101522, 2026. e-Pub 2026. PMID: 41621809.
— 2026cited by 0position: selected
Dasdemir, E, Veletic, I, Ly, C, Quesada, AE, Pacheco, CD, Jelloul, FZ, Borges, P, Basu, S, Jindal, S, Wang, Z, Lazar, A, Wani, K, Antunes, DA, Reville, PK, Gunaratne, PH, Tower, RJ, Sharma, P, Abbas, HA . Integrative spatial multi-omics reveal niche-specific inflammatory signaling and differentiatio
— 2026cited by 0position: selected
Majid, D, Wang, Z, Schalk, AM, Yuan, B, Tatarata, QZ, Root, J, Garza, AI, Yassouf, MY, Gamal, BT, Feri-Borgogno, S, Nguyen, AH, Konopleva, M, Peeters, E, Su, Y, Reville, PK, Ravandi-Kashani, F, Lavie, A, Abbas, HA . A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinic
— 2026cited by 0position: selected
Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of <i>JAK2</i>-mutated post-MPN AML
Karrar O, Kantarjian H, Haddad FG, Azevedo RS, Issa G, Ravandi F, Sasaki K, Senapati J, Abbas H, Dellasala S, Jabbour E, Short NJ . Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase. Leuk Lymphoma 66(12):2269-2276, 2025. e-
— 2025cited by 0position: selected
Han C, Zhang Z, Crosse EI, Sajedi S, Lu B, Wang X, Karma S, Kostich M, Rajendran SH, Udy DB, Chen S, Arnuk A, Lawal AE, Koenig KR, McKenna M, Reville PK, Abbas HA , Abdel-Wahab O, Miura P, Bradley RK, Wang E . An isoform-specific RUNX1C-BTG2 axis governs AML quiescence and chemoresistance. Blood Can
— 2025cited by 0position: selected
Senapati J, Kantarjian HM, Kadia TM, Kekedjian J, Borthakur G, Daver N, DiNardo CD, Jabbour E, Bose P, Short NJ, Yilmaz M, Jain N, Pemmaraju N, Abbas HA , Issa GC, Maiti A, Bravo GM, Deshmukh I, Shpall E, Kebriaei P, Popat U, Loghavi S, Thakral B, Tang G, Haddad FG, Alvarado Y, Manero GG, Ravandi F
— 2025cited by 0position: selected
Wang Z, Skwarska A, Poigaialwar G, Chaudhry S, Rodriguez-Meira A, Sui P, Olivier E, Jia Y, Gupta V, Fiskus W, Ramage CL, Zheng G, Schurer A, Gritsman K, Papapetrou EP, Bhalla KN, Zhou D, Mead AJ, Rampal RK, Tyner JW, Abbas HA , Pemmaraju N, Tatarata QZ, Konopleva MY . Efficacy of a Novel BCL-xL Degr
— 2025cited by 0position: selected
Ly CP, Veletic I, Pacheco CD, Dasdemir E, Jelloul FZ, Ferri-Borgogno S, Basi AV, Gomez JA, Root JL, Reville PK, Jindal S, Basu S, Sharma P, Quesada AE, Bueso-Ramos C, Manshouri T, Cuglievan B, Garcia M, Burks JK, Abbas HA . Multimodal spatial proteomic profiling in acute myeloid leukemia. NPJ Precis
— 2025cited by 0position: selected
Kugler E, Dasdemir E, Bataller A, Wang B, DiNardo CD, Daver N, Yilmaz M, Short NJ, Borthakur G, Kadia TM, Sasaki K, Hammond D, Bazinet A, Irajizad E, Thakral B, Pierce S, Reville P, Ravandi F, Abbas HA . Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletio
— 2025cited by 0position: selected
Jen W, Sasaki K, Ravandi F, Kadia TM, Wang SA, Wang W, Loghavi S, Daver NG, DiNardo CD, Issa GC, Abbas HA , Nasnas C, Bataller A, Urrutia S, Karrar OS, Pierce S, Kantarjian HM, Short NJ . Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy.
— 2025cited by 0position: selected
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia
Haddad FG, Sasaki K, Senapati J, Xiao L, Park G, Abuasab T, Venugopal S, Rivera D, Bazinet A, Babakhanlou R, Kim K, Ong F, Desikan S, Pemmaraju N, Loghavi S, Borthakur G, DiNardo C, Abbas HA , Short NJ, Daver N, Jabbour E, Garcia-Manero G, Ravandi F, Kantarjian H, Kadia T . Outcomes of Patients With
— 2024cited by 0position: selected
Li Z, Li R, Ganan-Gomez I, Abbas HA , Garcia-Manero G, Sun W . Accurate identification of locally aneuploid cells by incorporating cytogenetic information in single cell data analysis. Sci Rep 14(1):24152, 2024. e-Pub 2024. PMID: 39406835.
— 2024cited by 0position: selected
Bataller A, Kantarjian H, Bazinet A, Kadia T, Daver N, DiNardo CD, Borthakur G, Loghavi S, Patel K, Tang G, Sasaki K, Short NJ, Yilmaz M, Issa GC, Alvarado Y, Montalban-Bravo G, Maiti A, Abbas HA , Takahashi K, Pierce S, Jabbour E, Garcia-Manero G, Ravandi F . Outcomes and genetic dynamics of acute
— 2024cited by 0position: selected
Narayanan N, Marvin-Peek J, Abouelnaaj MK, Majid D, Wang B, Brown BD, Qiu Y, Kornblau SM, Abbas HA . Reverse Phase Proteomic Array Profiling of Asparagine Synthetase Expression in Newly Diagnosed Acute Myeloid Leukemia. J Proteome Res 23(7):2495-2504, 2024. e-Pub 2024. PMID: 38829961.
— 2024cited by 0position: selected
Marvin-Peek J, Sasaki K, Kontoyiannis DP, Adachi J, Ohanian M, Takahashi K, Issa GC, Kornblau S, Abbas HA . Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series. Front. Med 11, 2024. e-Pub 2024.
— 2024cited by 0position: selected
Kadia TM, Huang M, Pemmaraju N, Abbas HA , Ly C, Masarova L, Yilmaz M, Lyu MA, Zeng K, Sadeghi T, Cook R, DiNardo CD, Daver N, Issa GC, Jabbour E, Borthakur G, Jain N, Garcia-Manero G, Parmar S, Flowers C, Kantarjian H, Verstovsek S . Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndr
— 2024cited by 0position: selected
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
IFNγ Signaling in Acute Myeloid Leukemia Mediates Immunomodulation and Reveals Therapeutic Strategies
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia
Single Cell RNA-Seq Reveals Intra-Tumoral Heterogeneity Relevant to Differentiation States and Outcomes Among Newly Diagnosed Acute Myeloid Leukemia Patients
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates